AKT1 and type 2 diabetes mellitus: In fact, inhibiting the PI3K-Akt pathway has been shown to alleviate articular cartilage degeneration in OA (49), while activating this pathway has been found to improve insulin sensitivity, making it beneficial in the management of T2D (50).